By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Achillion Pharmaceuticals, Inc. 

300 George Street

New Haven  Connecticut  06511  U.S.A.
Phone: 203-624-7000 Fax: 203-624-7003



Drug Discovery

Company News
Two Drugmakers Johnson & Johnson (JNJ) May Consider Scooping Up 4/1/2016 7:46:24 AM
Achillion (ACHN) To Present At Two Upcoming Investor Conferences 3/3/2016 7:56:38 AM
Achillion (ACHN) Reports 2015 Fourth Quarter And Year-End Financial Results 2/25/2016 10:14:52 AM
Achillion (ACHN) Initiates Phase I Study Of ACH-4471, First Orally-Administered Small Molecule Complement Factor D Inhibitor 2/11/2016 7:14:55 AM
Achillion (ACHN) To Present At The Leerink Partners 5th Annual Global Healthcare Conference 2/9/2016 8:21:57 AM
Achillion (ACHN) Announces Appointments Of Martha Manning As General Counsel And Amy Jennings As Head Of Regulatory Affairs 2/3/2016 8:02:41 AM
Achillion (ACHN) Appoints Dr. Joel Barrish As Chief Scientific Officer 1/4/2016 7:12:25 AM
Achillion (ACHN) Appoints Dr. Frank Verwiel To Board Of Directors 12/17/2015 8:15:30 AM
Achillion (ACHN) Announces Upcoming Oral Presentation At The 57th Annual Meeting Of The American Society of Hematology And Nomination Of ACH-4471, A Novel Small Molecule Factor D Inhibitor, For Clinical Development 12/7/2015 8:27:46 AM
Achillion (ACHN) Reports Third Quarter And Nine Month 2015 Financial Results 11/6/2015 7:13:33 AM